![]() The reverse stock split will not affect the number of authorized shares of the Company’s common stock or the par value of the common stock. ![]() The Company’s common stock is expected to begin trading on a split-adjusted basis when the market opens on Octounder the existing trading symbol, “TTOO.”Īt the Company’s annual meeting of stockholders held on October 11, 2022, the Company’s stockholders representing approximately 70% of the voting power of the common stock and Series A preferred stock voting together as a single class approved the reverse stock split with the final ratio to be determined by the Board from within a range.Īs a result of the reverse stock split, each 50 shares of the Company’s common stock outstanding and held of record by each stockholder of the Company will be automatically reclassified and combined into one validly issued, fully paid and non-assessable share of common stock, subject to the treatment of fractional shares as described below. ![]() The reverse stock split will become effective today, October 12, 2022. ( NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced that the Company’s board of directors (the “Board”) has approved a reverse stock split of its common stock at a ratio of 1 post-split share for every 50 pre-split shares. ![]() 12, 2022 (GLOBE NEWSWIRE) - T2 Biosystems, Inc. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |